{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:37:03Z","timestamp":1793849823940,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Department of Biology, Faculty of Science, Chulalongkorn University"},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A670553"],"award-info":[{"award-number":["N42A670553"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Chikungunya virus (CHIKV), one of the arthropod-borne viruses, has been affecting the global population for more than 70 years since it was first described with more than 620,000 cases in 2024 alone. Despite its long-standing problem, the only treatment available for chikungunya-infected patients is supportive treatment to alleviate pain. Fluorescent molecules have been used in detecting viral infection in the host cells via immunofluorescence assays because of their sensitivity. This study aimed to use this assay to rapidly screen efficacy and cytotoxicity of several compounds in a high-throughput manner. The optimized conditions were to seed Vero cells at 10,000 cells\/well, and infect them with CHIKV ECSA at MOI of 0.1. These conditions resulted in a good discrimination power between infected wells and uninfected wells and minimized the cytopathic effect on host cells. Validation using two compounds with known activity against CHIKV, cycloheximide (CHX), and acyclovir (ACY), showed that the assay could properly identify active compounds and inactive compounds correctly. There was also no significant difference between the results of 3 independent rounds of compound screening, thus showing the reproducibility of the assay. Traditional primary screening were performed in parallel with the dual-color fluorescent assay for 60 unknown compounds to evaluate inhibition performance of inhibition and approximate cytotoxicity assessment. The results showed excellent performance from the analysis of the ROC curves and general agreement between two approaches from the Bland-Altman plots. Overall, the developed assay required less labor while being able to screen more compounds than the traditional assay in one round of experiment. The assay is currently being tested to screen libraries of compounds and so far, has been able to identify 22 hits for further characterization.<\/jats:p>","DOI":"10.1038\/s41598-025-16087-1","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T08:51:45Z","timestamp":1755852705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development, validation, and application of a dual-color fluorescent assay for high-throughput screening of anti-chikungunya drugs"],"prefix":"10.1038","volume":"15","author":[{"given":"Pattadon","family":"Sawetpiyakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duangpron","family":"Peypala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pathaphon","family":"Wiriwithya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gridsada","family":"Phanomchoeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanatorn","family":"Khotavivattana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warintorn","family":"Chavasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sittiporn","family":"Pattaradilokrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwaporn","family":"Boonyasuppayakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"1","key":"16087_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/0035-9203(55)90080-8","volume":"49","author":"MC Robinson","year":"1955","unstructured":"Robinson, M. C. An epidemic of virus disease in Southern province, Tanganyika territory, in 1952-53. I. Clinical features. Trans. R Soc. Trop. Med. Hyg. 49 (1), 28\u201332 (1955).","journal-title":"Trans. R Soc. Trop. Med. Hyg."},{"issue":"1","key":"16087_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0035-9203(55)90081-X","volume":"49","author":"WH Lumsden","year":"1955","unstructured":"Lumsden, W. H. An epidemic of virus disease in Southern province, Tanganyika territory, in 1952-53. II. General description and epidemiology. Trans. R Soc. Trop. Med. Hyg. 49 (1), 33\u201357 (1955).","journal-title":"Trans. R Soc. Trop. Med. Hyg."},{"issue":"Pt 11","key":"16087_CR3","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1099\/vir.0.2008\/005413-0","volume":"89","author":"M Kariuki Njenga","year":"2008","unstructured":"Kariuki Njenga, M. et al. Tracking epidemic Chikungunya virus into the Indian ocean from East Africa. J. Gen. Virol. 89 (Pt 11), 2754\u20132760 (2008).","journal-title":"J. Gen. Virol."},{"issue":"9602","key":"16087_CR4","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/S0140-6736(07)61779-6","volume":"370","author":"G Rezza","year":"2007","unstructured":"Rezza, G. et al. Infection with Chikungunya virus in italy: an outbreak in a temperate region. Lancet 370 (9602), 1840\u20131846 (2007).","journal-title":"Lancet"},{"issue":"suppl 5","key":"16087_CR5","doi-asserted-by":"publisher","first-page":"S441","DOI":"10.1093\/infdis\/jiw390","volume":"214","author":"S Yactayo","year":"2016","unstructured":"Yactayo, S. et al. Epidemiology of Chikungunya in the Americas. J. Infect. Dis. 214 (suppl 5), S441\u2013S445 (2016).","journal-title":"J. Infect. Dis."},{"key":"16087_CR6","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1017\/S0950268820000497","volume":"148","author":"F Deeba","year":"2020","unstructured":"Deeba, F. et al. Global transmission and evolutionary dynamics of the Chikungunya virus. Epidemiol. Infect. 148, e63 (2020).","journal-title":"Epidemiol. Infect."},{"key":"16087_CR7","doi-asserted-by":"crossref","unstructured":"Phadungsombat, J. et al. Spread of a novel Indian ocean lineage carrying E1-K211E\/E2-V264A of Chikungunya virus east\/central\/south African genotype across the Indian subcontinent, Southeast asia, and Eastern Africa. Microorganisms, 10(2). (2022).","DOI":"10.3390\/microorganisms10020354"},{"issue":"1","key":"16087_CR8","doi-asserted-by":"publisher","first-page":"7733","DOI":"10.1038\/s41598-018-26092-2","volume":"8","author":"S Cunze","year":"2018","unstructured":"Cunze, S. et al. Niche conservatism of Aedes albopictus and Aedes aegypti - two mosquito species with different invasion histories. Sci. Rep. 8 (1), 7733 (2018).","journal-title":"Sci. Rep."},{"issue":"6","key":"16087_CR9","doi-asserted-by":"publisher","first-page":"e0012254","DOI":"10.1371\/journal.pntd.0012254","volume":"18","author":"K Rama","year":"2024","unstructured":"Rama, K. et al. Clinical outcomes of chikungunya: A systematic literature review and meta-analysis. PLoS Negl. Trop. Dis. 18 (6), e0012254 (2024).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"16087_CR10","doi-asserted-by":"crossref","unstructured":"Tun, Y. M. et al. Virological, serological and clinical analysis of Chikungunya virus infection in Thai patients. Viruses, 14(8). (2022).","DOI":"10.3390\/v14081805"},{"issue":"24","key":"16087_CR11","doi-asserted-by":"publisher","first-page":"13878","DOI":"10.1128\/JVI.02666-13","volume":"87","author":"DW Hawman","year":"2013","unstructured":"Hawman, D. W. et al. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. J. Virol. 87 (24), 13878\u201313888 (2013).","journal-title":"J. Virol."},{"issue":"1","key":"16087_CR12","doi-asserted-by":"publisher","first-page":"2301573","DOI":"10.1080\/21505594.2023.2301573","volume":"15","author":"H Ly","year":"2024","unstructured":"Ly, H. Ixchiq (VLA1553): the first FDA-approved vaccine to prevent disease caused by Chikungunya virus infection. Virulence 15 (1), 2301573 (2024).","journal-title":"Virulence"},{"issue":"1","key":"16087_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41572-023-00429-2","volume":"9","author":"K Bartholomeeusen","year":"2023","unstructured":"Bartholomeeusen, K. et al. Chikungunya fever. Nat. Rev. Dis. Primers. 9 (1), 17 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"16087_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/app15010385","volume":"15","author":"P Wiriwithya","year":"2025","unstructured":"Wiriwithya, P. et al. Development of automated image processing for High-Throughput screening of potential Anti-Chikungunya virus compounds. Appl. Sci. 15 (1), 385 (2025).","journal-title":"Appl. Sci."},{"key":"16087_CR15","doi-asserted-by":"publisher","first-page":"104907","DOI":"10.1016\/j.antiviral.2020.104907","volume":"182","author":"Z Gao","year":"2020","unstructured":"Gao, Z. et al. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus. Antiviral Res. 182, 104907 (2020).","journal-title":"Antiviral Res."},{"issue":"5","key":"16087_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/2472555220911456","volume":"25","author":"I Vicenti","year":"2020","unstructured":"Vicenti, I. et al. Development of a Cell-Based immunodetection assay for simultaneous screening of antiviral compounds inhibiting Zika and dengue virus replication. SLAS Discov.. 25 (5), 506\u2013514 (2020).","journal-title":"SLAS Discov"},{"issue":"1","key":"16087_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12915-021-01086-1","volume":"19","author":"J Rietdijk","year":"2021","unstructured":"Rietdijk, J. et al. A phenomics approach for antiviral drug discovery. BMC Biol. 19 (1), 156 (2021).","journal-title":"BMC Biol."},{"key":"16087_CR18","doi-asserted-by":"crossref","unstructured":"Ding, C. et al. High-Throughput screening of FDA-Approved drug library reveals Ixazomib is a Broad-Spectrum antiviral agent against arboviruses. Viruses, 14(7). (2022).","DOI":"10.3390\/v14071381"},{"issue":"10","key":"16087_CR19","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1128\/jvi.2.10.955-961.1968","volume":"2","author":"J Desmyter","year":"1968","unstructured":"Desmyter, J., Melnick, J. L. & Rawls, W. E. Defectiveness of interferon production and of Rubella virus interference in a line of African green monkey kidney cells (Vero). J. Virol. 2 (10), 955\u2013961 (1968).","journal-title":"J. Virol."},{"issue":"2","key":"16087_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang, J. H., Chung, T. D. & Oldenburg, K. R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4 (2), 67\u201373 (1999).","journal-title":"J. Biomol. Screen."},{"issue":"3","key":"16087_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nchembio.304","volume":"6","author":"T Schneider-Poetsch","year":"2010","unstructured":"Schneider-Poetsch, T. et al. Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat. Chem. Biol. 6 (3), 209\u2013217 (2010).","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"16087_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.4103\/0378-6323.57716","volume":"75","author":"AK Nath","year":"2009","unstructured":"Nath, A. K. & Thappa, D. M. Newer trends in the management of genital herpes. Indian J. Dermatol. Venereol. Leprol. 75 (6), 566\u2013574 (2009).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"1","key":"16087_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","volume":"75","author":"FS Nahm","year":"2022","unstructured":"Nahm, F. S. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J. Anesthesiol. 75 (1), 25\u201336 (2022).","journal-title":"Korean J. Anesthesiol"},{"issue":"8476","key":"16087_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"1","author":"JM Bland","year":"1986","unstructured":"Bland, J. M. & Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (8476), 307\u2013310 (1986).","journal-title":"Lancet"},{"key":"16087_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-0348-1_7","volume":"1138","author":"KH Tan","year":"2014","unstructured":"Tan, K. H. et al. Cell-based flavivirus infection (CFI) assay for the evaluation of dengue antiviral candidates using high-content imaging. Methods Mol. Biol. 1138, 99\u2013109 (2014).","journal-title":"Methods Mol. Biol."},{"key":"16087_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.32614\/RJ-2016-042","volume":"8\/2","author":"D Goksuluk","year":"2016","unstructured":"Goksuluk, D. et al. EasyROC: an interactive Web-tool for ROC curve analysis using R Language environment. R J. 8\/2, 213\u2013230 (2016).","journal-title":"R J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16087-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16087-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16087-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:34:01Z","timestamp":1757446441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16087-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16087"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16087-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30860"}}